No. 2 - Room For Both "Wals"

Rite Aid (RAD) surprised The Street today by reporting a profitable Q1 driven by strong pharmacy sales growth. Can drug stores such as Rite Aid and Walgreen’s (WAG) survive the threat from four-dollar-pill-pusher Wal-Mart (WMT).

Guy Adami tells the panel he still likes Rite Aid because the Brooks Eckerd deal will save them $150 million a year in perpetuity. And the deal gives Rite-Aid national exposure.

Jeff Macke also likes the stock.

Eric Bolling says it’s not bad for an “under-$10 stock.”

Eric Bolling says it’s not bad for an “under-$10 stock.”

Got something to say? Send us an e-mail at and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to

Trader disclosure: On June 28 2007, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Najarian Owns (IMMR); Bolling Owns (DIS), (T), (XOM), Sugar, Gold